Risk factors identified in patient-to-patient transmission of resistant bacteria
NEW YORK (July 25, 2016) – Three key factors increase the risk for patient-to-patient transmission of an extremely drug-resistant bacteria known as CP-CRE, according to a new study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America. The research helps explain why some contacts of an infected patient acquire the dangerous bacteria while others do not.
"The spread of CP-CRE is a major public health concern because it is extremely drug resistant; however, the research on these pathogens is very limited, and so is our knowledge of their transmission," said Vered Schechner, MD, MSc, lead author of the study and an infection control physician in the department of epidemiology at Tel Aviv Sourasky Medical Center in Israel. "Identifying high-risk groups helps us to avoid excessive screening that can be risky and expensive, and to determine who should be screened and who might be a candidate for pre-emptive isolation or antibiotics."
CP-CRE, which stands for carbapenemase-producing carbapenem-resistant Enterobacteriacecae often affects patients in hospitals, nursing homes and other healthcare settings who require devices such as ventilators and catheters, and those who are taking long courses of certain antibiotics. Comparing infected patients with those showing no signs of CP-CRE, researchers found that 96 percent of patient-to-patient transmissions had at least one identified risk factor:
- Contact for more than three days with the infected individual;
- Mechanical ventilation; or
- Infection with another multidrug-resistant organism.
Additionally, researchers found that patients who had taken cephalosporins, a type of antibiotic, were less likely to acquire CP-CRE from another patient than those administered other antibiotics. Since antibiotic use is a risk factor for acquiring antibiotic-resistant organisms, it appears that cephalosporins might reduce the risk for CP-CRE compared to other drugs. However, there was no protective effect of cephalosporin when compared to patients receiving no antibiotics, and researchers said further study is needed.
The study was based on data from 3,158 adult inpatients who were screened for CP-CRE because of contact with another patient diagnosed with the pathogen between October 2008 and June 2012. In total, 53 patients were positive for CP-CRE and served as the case group, along with a group of 106 who had screened negative for CP-CRE.
Anat Schwartz-Neiderman, Tali Braun, Noga Fallach, David Schwartz, Yehuda Carmeli, Vered Schechner. "Risk factors for cabapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE) acquisition among contacts of newly diagnosed CP-CRE patients." Web (July 25, 2016).
Published through a partnership between the Society for Healthcare Epidemiology of America and Cambridge University Press, Infection Control & Hospital Epidemiology provides original, peer reviewed scientific articles for anyone involved with an infection control or epidemiology program in a hospital or healthcare facility. ICHE is ranked 13th out of 158 journals in its discipline in the latest Web of Knowledge Journal Citation Reports from Thomson Reuters.
SHEA is a professional society representing physicians and other healthcare professionals around the world with expertise and passion in healthcare epidemiology, infection prevention, and antimicrobial stewardship. SHEA's mission is to prevent and control healthcare-associated infections, improve the use of antibiotics in healthcare settings, and advance the field of healthcare epidemiology. SHEA improves patient care and healthcare worker safety in all healthcare settings through the critical contributions of healthcare epidemiology and improved antibiotic use. The society leads this specialty by promoting science and research, advocating for effective policies, providing high-quality education and training, and developing appropriate guidelines and guidance in practice. Visit SHEA online at http://www.shea-online.org, http://www.facebook.com/SHEApreventingHAIs and @SHEA_Epi
About Cambridge Journals
Cambridge University Press publishes over 350 peer-reviewed academic journals across a wide spread of subject areas, in print and online. Many of these journals are leading academic publications in their fields and together form one of the most valuable and comprehensive bodies of research available today.
For further information about Cambridge Journals, visit journals.cambridge.org
About Cambridge University Press
Cambridge University Press is part of the University of Cambridge. It furthers the University's mission by disseminating knowledge in the pursuit of education, learning and research at the highest international levels of excellence.
Its extensive peer-reviewed publishing lists comprise 45,000 titles covering academic research, professional development, over 350 research journals, school-level education, English language teaching and bible publishing.
Playing a leading role in today's international market place, Cambridge University Press has more than 50 offices around the globe, and it distributes its products to nearly every country in the world.
For further information about Cambridge University Press, visit cambridge.org